By Drug Target Review2023-10-26T16:00:23
Researchers have found that reducing glycosylation on the T cell surface may offer new approaches to cancer immunotherapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2026-03-11T14:00:00
Sponsored by Merck
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
Site powered by Webvision Cloud